Copyright Reports & Markets. All rights reserved.

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biologics
      • 1.4.3 Organic Compounds
    • 1.5 Market by Application
      • 1.5.1 Global Rare Endocrine Disease Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Rare Endocrine Disease Treatment Market Size
    • 2.2 Rare Endocrine Disease Treatment Growth Trends by Regions
      • 2.2.1 Rare Endocrine Disease Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Rare Endocrine Disease Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Rare Endocrine Disease Treatment Market Size by Manufacturers
      • 3.1.1 Global Rare Endocrine Disease Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rare Endocrine Disease Treatment Key Players Head office and Area Served
    • 3.3 Key Players Rare Endocrine Disease Treatment Product/Solution/Service
    • 3.4 Date of Enter into Rare Endocrine Disease Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Rare Endocrine Disease Treatment Market Size by Type (2014-2019)
    • 4.2 Global Rare Endocrine Disease Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 5.2 Rare Endocrine Disease Treatment Key Players in United States
    • 5.3 United States Rare Endocrine Disease Treatment Market Size by Type
    • 5.4 United States Rare Endocrine Disease Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 6.2 Rare Endocrine Disease Treatment Key Players in Europe
    • 6.3 Europe Rare Endocrine Disease Treatment Market Size by Type
    • 6.4 Europe Rare Endocrine Disease Treatment Market Size by Application

    7 China

    • 7.1 China Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 7.2 Rare Endocrine Disease Treatment Key Players in China
    • 7.3 China Rare Endocrine Disease Treatment Market Size by Type
    • 7.4 China Rare Endocrine Disease Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 8.2 Rare Endocrine Disease Treatment Key Players in Japan
    • 8.3 Japan Rare Endocrine Disease Treatment Market Size by Type
    • 8.4 Japan Rare Endocrine Disease Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 9.2 Rare Endocrine Disease Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Rare Endocrine Disease Treatment Market Size by Type
    • 9.4 Southeast Asia Rare Endocrine Disease Treatment Market Size by Application

    10 India

    • 10.1 India Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 10.2 Rare Endocrine Disease Treatment Key Players in India
    • 10.3 India Rare Endocrine Disease Treatment Market Size by Type
    • 10.4 India Rare Endocrine Disease Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Rare Endocrine Disease Treatment Market Size (2014-2019)
    • 11.2 Rare Endocrine Disease Treatment Key Players in Central & South America
    • 11.3 Central & South America Rare Endocrine Disease Treatment Market Size by Type
    • 11.4 Central & South America Rare Endocrine Disease Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Rare Endocrine Disease Treatment Introduction
      • 12.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Ipsen
      • 12.2.1 Ipsen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Rare Endocrine Disease Treatment Introduction
      • 12.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.2.5 Ipsen Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Rare Endocrine Disease Treatment Introduction
      • 12.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Teva
      • 12.4.1 Teva Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Rare Endocrine Disease Treatment Introduction
      • 12.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.4.5 Teva Recent Development
    • 12.5 EMD Serono
      • 12.5.1 EMD Serono Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Rare Endocrine Disease Treatment Introduction
      • 12.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.5.5 EMD Serono Recent Development
    • 12.6 Novo Nordisk
      • 12.6.1 Novo Nordisk Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Rare Endocrine Disease Treatment Introduction
      • 12.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.6.5 Novo Nordisk Recent Development
    • 12.7 Eli Lilly
      • 12.7.1 Eli Lilly Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Rare Endocrine Disease Treatment Introduction
      • 12.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.7.5 Eli Lilly Recent Development
    • 12.8 Shire
      • 12.8.1 Shire Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Rare Endocrine Disease Treatment Introduction
      • 12.8.4 Shire Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.8.5 Shire Recent Development
    • 12.9 Amgen
      • 12.9.1 Amgen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Rare Endocrine Disease Treatment Introduction
      • 12.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.9.5 Amgen Recent Development
    • 12.10 Corcept Therapeutics
      • 12.10.1 Corcept Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Rare Endocrine Disease Treatment Introduction
      • 12.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
      • 12.10.5 Corcept Therapeutics Recent Development
    • 12.11 Novelion Therapeutics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
      The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.
      In 2018, the global Rare Endocrine Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Endocrine Disease Treatment development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Ipsen
      Pfizer
      Teva
      EMD Serono
      Novo Nordisk
      Eli Lilly
      Shire
      Amgen
      Corcept Therapeutics
      Novelion Therapeutics

      Market segment by Type, the product can be split into
      Biologics
      Organic Compounds

      Market segment by Application, split into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Rare Endocrine Disease Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Rare Endocrine Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now